US 12391669
Substituted pyrimidines as IRE1 kinase inhibitors
granted A61PA61P25/16A61P25/28
Quick answer
US patent 12391669 (Substituted pyrimidines as IRE1 kinase inhibitors) held by The Regents of the University of California et al. expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California et al.
- Grant date
- Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P25/16, A61P25/28, A61P29/00